JPH0421691A - Production of phosphatidylcholine derivative and its analog and their intermediate - Google Patents
Production of phosphatidylcholine derivative and its analog and their intermediateInfo
- Publication number
- JPH0421691A JPH0421691A JP12388790A JP12388790A JPH0421691A JP H0421691 A JPH0421691 A JP H0421691A JP 12388790 A JP12388790 A JP 12388790A JP 12388790 A JP12388790 A JP 12388790A JP H0421691 A JPH0421691 A JP H0421691A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- compound represented
- ion
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 150000008105 phosphatidylcholines Chemical class 0.000 title claims description 18
- 150000001875 compounds Chemical class 0.000 claims abstract description 76
- -1 sulfuric acid ion Chemical class 0.000 claims abstract description 34
- 239000000126 substance Substances 0.000 claims abstract description 20
- 150000003512 tertiary amines Chemical class 0.000 claims abstract description 19
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 12
- 239000011574 phosphorus Substances 0.000 claims abstract description 12
- 125000005843 halogen group Chemical group 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 239000002994 raw material Substances 0.000 abstract description 9
- 239000002502 liposome Substances 0.000 abstract description 3
- 150000002500 ions Chemical class 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 30
- 239000000243 solution Substances 0.000 description 19
- 239000002904 solvent Substances 0.000 description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 150000002314 glycerols Chemical class 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 8
- 239000013078 crystal Substances 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 3
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 229940126657 Compound 17 Drugs 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229940100890 silver compound Drugs 0.000 description 3
- 150000003379 silver compounds Chemical class 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001342 alkaline earth metals Chemical class 0.000 description 2
- 229940077388 benzenesulfonate Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229940125904 compound 1 Drugs 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910001958 silver carbonate Inorganic materials 0.000 description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- UNSAJINGUOTTRA-UHFFFAOYSA-N 3-(3-bromophenyl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=CC(Br)=C1 UNSAJINGUOTTRA-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- VIZQREHVDDPWOK-UHFFFAOYSA-N IP(I)(I)=O Chemical compound IP(I)(I)=O VIZQREHVDDPWOK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- GDCXBZMWKSBSJG-UHFFFAOYSA-N azane;4-methylbenzenesulfonic acid Chemical compound [NH4+].CC1=CC=C(S([O-])(=O)=O)C=C1 GDCXBZMWKSBSJG-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- SUHOQUVVVLNYQR-MRVPVSSYSA-N choline alfoscerate Chemical class C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-N 0.000 description 1
- KILNVBDSWZSGLL-UHFFFAOYSA-N colfosceril palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-UHFFFAOYSA-N 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- VRZVPALEJCLXPR-UHFFFAOYSA-N ethyl 4-methylbenzenesulfonate Chemical compound CCOS(=O)(=O)C1=CC=C(C)C=C1 VRZVPALEJCLXPR-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- PTFDTQDDWWQYMG-UHFFFAOYSA-N methanamine;4-methylbenzenesulfonic acid Chemical compound [NH3+]C.CC1=CC=C(S([O-])(=O)=O)C=C1 PTFDTQDDWWQYMG-UHFFFAOYSA-N 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- CZXGXYBOQYQXQD-UHFFFAOYSA-N methyl benzenesulfonate Chemical compound COS(=O)(=O)C1=CC=CC=C1 CZXGXYBOQYQXQD-UHFFFAOYSA-N 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- WTBAHSZERDXKKZ-UHFFFAOYSA-N octadecanoyl chloride Chemical compound CCCCCCCCCCCCCCCCCC(Cl)=O WTBAHSZERDXKKZ-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 1
- FFUQCRZBKUBHQT-UHFFFAOYSA-N phosphoryl fluoride Chemical compound FP(F)(F)=O FFUQCRZBKUBHQT-UHFFFAOYSA-N 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 150000003248 quinolines Chemical group 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、リポソームの素材等として有用なホスファチ
ジルコリン誘導体の製造方法及びその中間体に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing a phosphatidylcholine derivative useful as a material for liposomes, and intermediates thereof.
[従来の技術]
ホスファチジルコリン鰐導体の製造方法としては、大別
して、グリセロホスファチジルコリン誘導体を原料とし
、これをジアシル化する方法と、ジアシル化グリセロー
ルを原料とし、これにコリン基を導入する方法がある。[Prior Art] Methods for producing phosphatidylcholine crocodile conductors can be roughly divided into two methods: a method in which a glycerophosphatidylcholine derivative is used as a raw material and diacylated, and a method in which a diacylated glycerol is used as a raw material and a choline group is introduced therein.
このうち、ジアシル化グリセロールを原料とするホスフ
ァチジルコリン誘導体の合成方法としては、Liebi
gs Ann、Ches+、709,226−230
(1967)に記載の方法が知られている。Among these, as a method for synthesizing phosphatidylcholine derivatives using diacylated glycerol as a raw material,
gs Ann, Ches+, 709, 226-230
(1967) is known.
この方法は下記反応式で示すように、2,2−ジアシル
化グリセロールとシクロロリン酸β−ブロムエチルを縮
合させて1,2−ジアシル化グリセロールモノクロロリ
ン酸β−ブロムエチルを合成し、これを加水分解して脱
塩素化し、1,2−ジアシル化グリセロール−リン酸β
−ブロムエチルエステルとなし、これにトリメチルアミ
ンを縮合させて、ホスファチジルコリン・臭化水素塩を
得、これを炭酸銀で脱臭化水素する方法である。As shown in the reaction formula below, this method condenses 2,2-diacylated glycerol and β-bromoethyl cyclophosphate to synthesize β-bromoethyl 1,2-diacylated glycerol monochlorophosphate, which is then hydrolyzed. dechlorinated and 1,2-diacylated glycerol-phosphate β
- bromoethyl ester, condensation of this with trimethylamine to obtain phosphatidylcholine hydrobromide, and dehydrobromide with silver carbonate.
CH20COR
CH20COR
CH20COR
C)120COR
H
H
↓A8.C03
CH20COR
CH0COR
CH20PO2CH2CH2N”(CH3)3[発明が
解決しようとする課題]
しかし、この方法で使用するトリメチルアミンは沸点(
4℃)が極めて低いため、縮合反応時反応系外に蒸発し
環境汚染の問題を生しる。また、合成の最終段階での炭
酸銀の使用は種々の問題を生しる。即ち、得られたホス
ファチジルコリン誘導体が医薬品のリポソーム製剤用原
料として使用される場合には、銀化合物の残存を防止す
るために極めて厳密な精製が要求され、また、一方、環
境保全の観点から、製造に際して生ずる廃液中の銀イオ
ンの回収という煩雑な操作が要求されるのである。CH20COR CH20COR CH20COR C)120COR H H ↓A8. C03 CH20COR CH0COR CH20PO2CH2CH2N"(CH3)3 [Problem to be solved by the invention] However, the trimethylamine used in this method has a boiling point (
(4°C) is extremely low, it evaporates outside the reaction system during the condensation reaction, causing environmental pollution problems. Also, the use of silver carbonate in the final stage of synthesis poses various problems. That is, when the obtained phosphatidylcholine derivatives are used as raw materials for liposome formulations of pharmaceuticals, extremely strict purification is required to prevent residual silver compounds. This requires a complicated operation of recovering silver ions from the waste liquid produced during this process.
本発明の目的は、かかる課題を解決し、ホスファチジル
コリン誘導体の簡易な製造方法を提供することにある。An object of the present invention is to solve this problem and provide a simple method for producing phosphatidylcholine derivatives.
[課題を解決するための手段]
本発明者らは、上記の課題を解決すべくホスファチジル
コリン誘導体の新規な製造方法につき、鋭意研究した結
果、トリメチルアミンや銀化合物を使用しない簡易な方
法を見出し、本発明を完成するに至った。[Means for Solving the Problems] In order to solve the above problems, the present inventors have conducted intensive research into a new method for producing phosphatidylcholine derivatives, and as a result, have discovered a simple method that does not use trimethylamine or silver compounds. The invention was completed.
本発明は、式[I1
%式%
[]
(式中、R1は炭素数10〜24の直鎖状又は分枝状の
アルキル基を表す。)
で示される化合物に、オキシハロゲン化リンを反応させ
て、式[I1]
%式%
(式中、
Xはハロゲン原子を表し、
R1は前記と
同し。)
て示される化合物とし、三級アミンの存在下、これに、
式[■コ
HO(CH2)−N“R弓・Y−[ml(式中、R2は
低級アルキル基を表し、Y−は硫酸イオン、アルキル硫
酸イオン又はスルホン酸イオンを表し、nは2〜10の
整数を表す。)で示される化合物を反応させ、次いて、
塩基性物質の存在下、水と反応させる、式[IV]CH
20COR1
(式中、R+、R2及びnは前記と同し。)で示される
ホスファチジルコリン誘導体の製造方法の発明である。In the present invention, phosphorus oxyhalide is reacted with a compound represented by the formula [I1% formula% [] (wherein R1 represents a linear or branched alkyl group having 10 to 24 carbon atoms). Then, in the presence of a tertiary amine, a compound represented by the formula [I1] % formula % (wherein, X represents a halogen atom, and R1 is the same as above),
Formula [■KOHO(CH2)-N"R-Y-[ml (wherein, R2 represents a lower alkyl group, Y- represents a sulfate ion, an alkyl sulfate ion, or a sulfonate ion, and n is 2- (represents an integer of 10) is reacted, and then,
Reacted with water in the presence of a basic substance, formula [IV] CH
This invention relates to a method for producing a phosphatidylcholine derivative represented by 20COR1 (wherein R+, R2 and n are the same as above).
また、本発明は、式[I1] %式% (式中、R1及びXは前記と同し。) で示される化合物の発明である。Further, the present invention provides the formula [I1] %formula% (In the formula, R1 and X are the same as above.) This is an invention of a compound represented by
即ち、本発明は、1,2−ジアシル化グリセロールの水
酸基にジハロゲノホスホリル基を導入し、そのハロゲン
原子の一つを、予め4級アンモニウム塩化したアルコー
ルと置換して、1.2−ジアシル化グリセロールのモノ
ハロケノリン酸エステルとなし、これを塩基性物質の存
在下、水で処理して、脱ハロゲン原子反応と分子内塩化
を同時に行う、ホスファチジルコリン誘導体の製造方法
の発明、及び、その方法の中間体となる化合物の発明で
ある。That is, the present invention introduces a dihalogenophosphoryl group into the hydroxyl group of 1,2-diacylated glycerol, and replaces one of the halogen atoms with an alcohol that has been converted into a quaternary ammonium salt in advance to achieve 1,2-diacylated glycerol. Invention of a method for producing a phosphatidylcholine derivative, which involves forming a monohalokenophosphate of glycerol and treating this with water in the presence of a basic substance to simultaneously perform a dehalogenation reaction and intramolecular salification, and an intermediate for the method. This is an invention of a compound that becomes
以下に本発明の詳細な説明する。The present invention will be explained in detail below.
まず、前記の式で示される化合物について説明すると、
式[I]で示される化合物は、グリセロ〜ル骨格の2−
位に不斉炭素を有し、0一体及びL−00光学異性体が
存在するが、その各々、或はそtらの混合物のいずれを
も含み、いずれを使用しマも本発明の方法を適用できる
。式[I1におけイR1としては、炭素数10〜24の
アルキル基てあれば特に制約はなく、例えば、デシル基
、トリアらル基、ペンタデシル基、ヘプタデシル基、イ
コシル基及びテトラコシル基等の直鎖状アルキル基、ブ
チルヘキシル基、トリメチルウンデシル基、(トリメチ
ルブチル)トリメチルへブチル基、ヘプチルデシル基、
ジブチルドデシル基等の分校状フルキル基が挙げられる
。First, to explain the compound represented by the above formula,
The compound represented by formula [I] has a glycerol skeleton of 2-
It has an asymmetric carbon at the position, and there are 0-isomers and L-00 optical isomers, and the method of the present invention can be carried out using either of them or a mixture thereof. Applicable. In the formula [I1, R1 is not particularly limited as long as it is an alkyl group having 10 to 24 carbon atoms. Chain alkyl group, butylhexyl group, trimethylundecyl group, (trimethylbutyl)trimethylhebutyl group, heptyldecyl group,
Examples include branched furkyl groups such as dibutyldodecyl groups.
式[I1]におけるR1は式[I]の場合と同一の基が
例示でき、式[I1]におけるXはその製建の際に用い
たオキシハロゲン化リンと同一のハロゲン原子である。R1 in formula [I1] can be exemplified by the same group as in formula [I], and X in formula [I1] is the same halogen atom as the phosphorus oxyhalide used in its construction.
式[I11]におけるR2としては、例えば、メチル基
、エチル基、プロピル基、イソプロピル基。R2 in formula [I11] is, for example, a methyl group, an ethyl group, a propyl group, or an isopropyl group.
ブチル基、イソブチル基、 5ec−ブチル基及びte
rブチル基等の、低級アルキル基が挙げられ、Yとして
は、例えば、硫酸イオン、メチル硫酸イオン、エチル硫
酸イオン等のアルキル硫酸イオン、メタンスルホン酸イ
オン、エタンスルホン酸イオン、ベンゼンスルホン酸イ
オン、p−トルエンスルホン酸イオン等の脂肪族又は芳
香族のスルホン酸イオン等が挙げられ、特にアルキル硫
酸イオン、芳香族スルホン酸イオンが好ましい。更に、
式[I11]におけるnは、2〜10の整数であるが、
2〜5の整数がより好ましく、特に2又は3が好ましい
。Butyl group, isobutyl group, 5ec-butyl group and te
Examples of Y include lower alkyl groups such as r-butyl group, and examples of Y include alkyl sulfate ions such as sulfate ion, methyl sulfate ion, and ethyl sulfate ion, methanesulfonate ion, ethanesulfonate ion, benzenesulfonate ion, Examples include aliphatic or aromatic sulfonate ions such as p-toluenesulfonate ion, and particularly preferred are alkyl sulfate ions and aromatic sulfonate ions. Furthermore,
n in formula [I11] is an integer of 2 to 10,
An integer of 2 to 5 is more preferred, and 2 or 3 is particularly preferred.
式[■コにおけるR1.R2及びnは、式[I]。R1. R2 and n are formula [I].
式[I1]及び式[mlの場合と同一の基を例示するこ
とができる。The same groups as in the case of formula [I1] and formula [ml can be exemplified.
前記の式で示される化合物のうち、式[I]で示される
化合物の製法は、J、Chem、Soc、、1951.
2663に記載されており、また、式[mlて示される
化合物の製法は、Chem、Phars、Bu 11.
.37.1249(1989)に記載されているから、
それらに準して製造すればよい。Among the compounds represented by the above formulas, the method for producing the compound represented by formula [I] is described in J. Chem, Soc, 1951.
2663, and the method for preparing the compound represented by the formula [ml] is described in Chem, Phars, Bu 11.
.. 37.1249 (1989),
It may be manufactured according to these.
次に本発明の製造方法について説明する。Next, the manufacturing method of the present invention will be explained.
まず、式[I1]で示される化合物は、式[I1て示さ
れる化合物とオキシハロゲン化リンとを一定の仕込み比
で混合し、所定温度にて所定時間攪拌することによりな
され、反応に際し、適当な溶媒を使用し、また、三級ア
ミンを添加して反応を促進させるのが好ましい。First, the compound represented by formula [I1] is prepared by mixing the compound represented by formula [I1] and phosphorus oxyhalide at a fixed charging ratio, and stirring the mixture at a prescribed temperature for a prescribed time. It is preferable to use a suitable solvent and to add a tertiary amine to accelerate the reaction.
この反応に使用するオキシハロゲン化リンとしては、例
えば、オキシ塩化リン、オキシ臭化リンオキシフッ化リ
ン及びオキシヨウ化リンが挙げられ、特にオキシ塩化リ
ンが好ましい。また、その使用量は特に制約はないが、
反応を完全に進行させるためには、式[I1て示される
化合物に対し等モル以上が必要である。通常は、次工程
におけるオキシハロゲン化リンの残存をできるだけ抑制
するため、0.01〜0.05倍程度過剰のモル比て使
用される。式[Iコて示される化合物とオキシハロゲン
化リンとの混合は、オキシハロゲン化リン中に式[IF
で示される化合物を徐々に添加する方法で行われる。溶
媒を使用する場合は、式[I]で示される化合物を溶液
で滴下する方法が採用てき、反応が円滑に進行するので
特に好ましい。この場合、式[I1て示される化合物の
みを溶解してもよく、式[I]で示される化合物とオキ
シハロゲン化リンとの双方を夫々溶解してもよい。使用
し得る溶媒としては、原料を溶解し、且つ、それ自体反
応しない溶媒であればいずれてもよく、その具体例とし
ては、例えば、塩化メチレン、クロロホルム、四塩化炭
素、ジクロルエタン、クロルヘンゼン等のハロゲン化炭
化水素、ヘンゼン。Examples of the phosphorus oxyhalide used in this reaction include phosphorus oxychloride, phosphorus oxybromide, phosphorus oxyfluoride, and phosphorus oxyiodide, with phosphorus oxychloride being particularly preferred. In addition, there are no particular restrictions on its usage, but
In order for the reaction to proceed completely, it is necessary to use the compound in an amount equal to or more than the equivalent mole of the compound represented by formula [I1]. Usually, in order to suppress the residual phosphorus oxyhalide in the next step as much as possible, a molar excess of about 0.01 to 0.05 times is used. Mixing a compound of the formula [I] with a phosphorus oxyhalide produces a compound of the formula [IF
This is done by gradually adding the compound shown in . When a solvent is used, a method in which a solution of the compound represented by formula [I] is added dropwise is adopted, which is particularly preferred since the reaction proceeds smoothly. In this case, only the compound represented by formula [I1] may be dissolved, or both the compound represented by formula [I] and the phosphorus oxyhalide may be dissolved respectively. Any solvent that can be used may be used as long as it dissolves the raw materials and does not react with itself. Specific examples include halogenated solvents such as methylene chloride, chloroform, carbon tetrachloride, dichloroethane, and chlorohenzene. hydrogenated hydrocarbons, Hensen.
トルエン、キシレン等の芳香族炭化水素、ジエチルエー
テル、テトラヒドロフラン、ジオキサン。Aromatic hydrocarbons such as toluene and xylene, diethyl ether, tetrahydrofuran, and dioxane.
エチレングリコールジメチルエーテル等のエーテル類、
酢酸エチル等のエステル類、ホルムアミド。Ethers such as ethylene glycol dimethyl ether,
Esters such as ethyl acetate, formamide.
N、N−ジメチルホルムアミド等のアミド類が挙げられ
、ハロゲン化炭化水素がより好ましく、特にクロロホル
ムが好ましい。また、これら溶媒は単独で使用しても、
二種以上を混合して用いてもよい。Amides such as N,N-dimethylformamide are mentioned, halogenated hydrocarbons are more preferred, and chloroform is particularly preferred. Moreover, even if these solvents are used alone,
Two or more types may be mixed and used.
これら溶媒の使用量は、原料を溶解し得る量てあフて、
且つ、反応速度を極端に低下させない量であれは特に制
約はないが、通常、式[I]で示される化合物1モルに
対して、全量が3〜20Lであるように使用され、好ま
しくは、5〜15Lである。The amount of these solvents to be used depends on the amount that can dissolve the raw materials,
In addition, there is no particular restriction as long as the amount does not extremely reduce the reaction rate, but it is usually used in a total amount of 3 to 20 L per mol of the compound represented by formula [I], and preferably, It is 5-15L.
本反応の温度は、反応が支障なく進行し得る程度であれ
ばよいが、一般の化学反応と同様に低温の方が副反応を
避けることができ、例えば、−20〜+40℃の範囲で
行うのが好ましい。尚、本反応を、低温で円滑に進行さ
せるためには三級アミンを添加するのが効果的であり、
添加し得る三級アミンの具体例としては、例えば、トリ
エチルアミン。The temperature of this reaction may be as long as the reaction can proceed without any problems, but as with general chemical reactions, side reactions can be avoided at lower temperatures; for example, it is carried out in the range of -20 to +40°C. is preferable. In addition, in order to make this reaction proceed smoothly at low temperature, it is effective to add a tertiary amine.
A specific example of the tertiary amine that can be added is triethylamine.
N、N−ジメチルアニリン及びピリジン等が挙げられ、
特にトリエチルアミンが好ましい。また、その使用量は
式[I]で示される化合物より過剰であればよいが、反
応を更に円滑に進行させるためには、通常、オキシハロ
ゲン化リン1モルに対し2〜10モルが使用される。三
級アミンの添加の時期としては、反応途中に滴下等して
もよいが、当初から添加する方が効果的であり、式[■
コて示される化合物、オキシハロゲン化リンのいずれと
優先して混合してもよい。反応の進行は、例えば、反応
液の一部を適当なアルコールと混合して生成物をエステ
ル化する等して安定な化合物に変換してから、例えば、
薄層クロマトグラフィー等で容易に観察することができ
る。Examples include N,N-dimethylaniline and pyridine,
Particularly preferred is triethylamine. The amount used may be in excess of the compound represented by formula [I], but in order to make the reaction proceed more smoothly, it is usually used in an amount of 2 to 10 moles per mole of phosphorus oxyhalide. Ru. Regarding the timing of addition of the tertiary amine, it may be added dropwise during the reaction, but it is more effective to add it from the beginning.
It may be preferentially mixed with any of the compounds shown above and phosphorus oxyhalide. The reaction progresses by, for example, mixing a part of the reaction solution with an appropriate alcohol to esterify the product, converting it into a stable compound, and then, for example,
It can be easily observed by thin layer chromatography or the like.
反応終了後は、濃縮、再溶解、濾過、結晶化等の通常の
操作を施し、生成物を単離精製してもよいが、操作を簡
略にし、また、生成物の分解等を避けるためにも、通常
は単離せずに反応液のままで次工程に使用される。After completion of the reaction, the product may be isolated and purified by performing usual operations such as concentration, redissolution, filtration, and crystallization, but in order to simplify the operation and avoid decomposition of the product, etc. Also, the reaction solution is usually used in the next step without isolation.
次に、本発明の目的物たる式[IV]で示されるホスフ
ァチジルコリン誘導体の製造は、上記の如くして得られ
た式[n]で示される化合物の溶液に、三級アミンの存
在下、前記式[■]て示される化合物を徐々に加え、所
定温度にて所定時間反応させた後、塩基性物質の存在下
、水で処理することにより行われる。Next, the production of the phosphatidylcholine derivative represented by the formula [IV], which is the object of the present invention, is carried out by adding the above-described compound to the solution of the compound represented by the formula [n] in the presence of a tertiary amine. This is carried out by gradually adding a compound represented by the formula [■], reacting at a predetermined temperature for a predetermined time, and then treating with water in the presence of a basic substance.
前記式[I[]て示される化合物を溶解するための溶媒
の種類及びその量としては、式[II]て示される化合
物の製造方法の説明で挙げた溶媒の種類及び量がそのま
ま例示される。従って、前工程の反応液をそのまま使用
する場合には、何ら新たに溶媒を添加することを要さず
、溶解のための操作も要さない。式[III]で示され
る化合物の使用量としては、式[I[]で示される化合
物より過剰量であれば、特に制約はないが、通常、式[
I11て示される化合物1モルに対して、1〜2モルの
範囲で使用される。尚、前工程の反応液をそのまま使用
する場合には、式[III]で示される化合物の使用量
の計算の基礎となる式[I1]で示される化合物のモル
数は、前工程の原料である式[I1て示される化合物の
モル数を用いることができる。Examples of the type and amount of the solvent for dissolving the compound represented by formula [I[] are the types and amounts of solvents listed in the explanation of the method for producing the compound represented by formula [II]. . Therefore, when the reaction solution from the previous step is used as it is, there is no need to add any new solvent and no operation for dissolution is required. The amount of the compound represented by formula [III] to be used is not particularly limited as long as it is in excess of the compound represented by formula [I].
It is used in an amount of 1 to 2 mol per 1 mol of the compound represented by I11. In addition, when the reaction solution from the previous step is used as it is, the number of moles of the compound represented by formula [I1], which is the basis for calculating the usage amount of the compound represented by formula [III], is based on the raw material from the previous step. The number of moles of a compound represented by a certain formula [I1 can be used.
反応に際して存在すべき三級アミンの具体例としては、
例えば、トリエチルアミン、 N、N−ジメチルアニリ
ン及びピリジン等が挙げられ、特にピリジンが好ましい
。また、その量は式[I11]で示される化合物より過
剰であればよい。尚、式[mlて示される化合物を溶液
で滴下する場合は、式[I1]で示される化合物の製造
方法の説明の際に例示した溶媒のいずれかを使用するこ
とも可能であるが、複雑な溶媒系を避けるためにも、こ
の三級アミンを溶媒とするのが好ましい。その場合は、
溶解に必要な最小限の三級アミンが使用されるが、その
量はアミンの種類及び式[mlで示される化合物の種類
により、例えば、式[I11]で示される化合物の重量
の200倍以上に達する場合もある。また、前工程で、
式[I]で示される化合物より過剰の三級アミンを使用
した場合において、式[I1]で示される化合物を前工
程の反応液のまま使用する場合には、既に一定量の三級
アミンが存在しているので、本工程で添加する三級アミ
ンの量は、その不足分て足り、また、既に十分に存在し
ていれば、新たに添加することを要しない。Specific examples of tertiary amines that should be present during the reaction include:
Examples include triethylamine, N,N-dimethylaniline and pyridine, with pyridine being particularly preferred. Further, the amount thereof may be in excess of the compound represented by formula [I11]. In addition, when dropping the compound represented by the formula [ml] as a solution, it is possible to use any of the solvents exemplified in the explanation of the method for producing the compound represented by the formula [I1]; In order to avoid a harsh solvent system, it is preferable to use this tertiary amine as a solvent. In that case,
The minimum amount of tertiary amine necessary for dissolution is used, but the amount depends on the type of amine and the type of compound represented by formula [ml], for example, 200 times or more the weight of the compound represented by formula [I11]. In some cases, it reaches . Also, in the previous process,
When using an excess of tertiary amine compared to the compound represented by formula [I], if the compound represented by formula [I1] is used as the reaction solution from the previous step, a certain amount of tertiary amine has already been used. Since the tertiary amine is already present, the amount of tertiary amine added in this step is sufficient to compensate for the shortage, and if it is already present in sufficient quantity, there is no need to add any more.
本反応の温度も、式[I1]で示される化合物の製造の
場合と同しく、反応が支障なく進行し得る程度であれば
特に制約はないが、低温の方が好ましく、例えば、−2
0〜+40℃の範囲で行なわれる。The temperature of this reaction is also not particularly limited, as long as the reaction can proceed without any problem, as in the case of producing the compound represented by formula [I1], but a low temperature is preferable, for example -2
The temperature range is 0 to +40°C.
反応の進行は、薄層クロマトグラフィーで容易に観察す
ることができる。The progress of the reaction can be easily observed by thin layer chromatography.
縮合反応終了後に水と共に添加すべき塩基性物質として
は、例えば、水酸化ナトリウム、水酸化カリウム、水酸
化カルシウム等のアルカリ土属又はアルカリ土類金属の
水酸化物、炭酸ナトリウム炭酸カリウム、炭酸カルシウ
ム等のアルカリ金属又はアルカリ土類金属の炭酸塩、炭
酸水素ナトリウム、炭酸水素カリウム等のアルカリ金属
の炭酸水素塩、トリエチルアミン、 N、N−ジメチル
アニリン及びピリジン等の三級アミン等が挙げられ、特
にアルカリ金属の炭酸水素塩が好ましい。水及び塩基性
物質の使用量は、使用した式[II[]で示される化合
物と等モル乃至それ以上であれば特に制約はないが、通
常は式[■コて示される化合物に対し、水については、
5〜500倍モルであり、塩基性物質については、2〜
100倍モルである。尚、式[I11]で示される化合
物を反応させる際に存在していた三級アミンが、式[m
]で示される化合物よりも過剰であった場合には、その
残存量によっては、塩基性物質の添加量を減少し、又は
、添加そのものを省略することもてきる。Examples of basic substances to be added together with water after the condensation reaction are hydroxides of alkaline earth or alkaline earth metals such as sodium hydroxide, potassium hydroxide, and calcium hydroxide, sodium carbonate, potassium carbonate, and calcium carbonate. carbonates of alkali metals or alkaline earth metals such as, alkali metal hydrogencarbonates such as sodium bicarbonate and potassium bicarbonate, tertiary amines such as triethylamine, N,N-dimethylaniline and pyridine, etc. Alkali metal bicarbonates are preferred. There is no particular restriction on the amount of water and basic substance used as long as it is equimolar or more than the compound represented by the formula [II[] used, but usually water and the amount of water about,
5 to 500 times the molar amount, and for basic substances, 2 to 500 times the molar amount.
It is 100 times the molar amount. In addition, the tertiary amine that was present when reacting the compound represented by formula [I11] was replaced by the compound represented by formula [m
] If the amount of the basic substance is in excess of the compound represented by , the amount of the basic substance added may be reduced or the addition itself may be omitted depending on the remaining amount.
加水分解後は、水層を分離した後、有機層を濃縮し、適
当な溶媒てカラムクロマトグラフィーに付せば、目的と
するホスファチジルコリン誘導体溶液が得られるから、
これに濃縮、沈殿、結晶化等、通常の単!i操作を施せ
ばよい。得られたホスファチジルコリン誘導体は、必要
に応じ、再結晶、再カラムクロマトグラフィー処理等し
て、更に精製することができる。After hydrolysis, the desired phosphatidylcholine derivative solution can be obtained by separating the aqueous layer, concentrating the organic layer, and subjecting it to column chromatography using an appropriate solvent.
This includes concentration, precipitation, crystallization, etc., as usual! All you have to do is perform the i operation. The obtained phosphatidylcholine derivative can be further purified by recrystallization, recrystallization, column chromatography, etc., if necessary.
以下に実施例を挙げるが、本発明はこれら実施例により
同等限定されるものではない。尚、実施例に記載した式
[Iコ、[II] 、[m]で示される化合物及び式[
IV]で示されるホスファチジルコリン誘導体の収率、
融点、IR,NMR及び比旋光度の各測定結果は表1,
2及び3にまとめて記載した。Examples are given below, but the present invention is not limited to the same extent by these Examples. In addition, the compounds represented by the formulas [I, [II], [m] and the formula [
IV] yield of phosphatidylcholine derivative,
The measurement results of melting point, IR, NMR, and specific rotation are shown in Table 1.
2 and 3 are listed together.
[実施例]
参考例11.2−ジアシル化グリセロールの製造(1)
式[]においてR1= n−C15)131である化合
物のラセミ体
DL−2,3−イソプロピリデングリセロール66.1
g(0,5*ol)をトルエン400m1に溶解し、金
属ナトリウム11.5g (0,5*ol)を加えて、
攪拌上還流した。2時間経過後、臭化ヘンシル85.5
g (0,5−01)を1時閏を要して滴下し、そのま
まIR閏還流した。[Example] Reference Example 11. Production of 2-diacylated glycerol (1)
Racemic form of the compound DL-2,3-isopropylidene glycerol 66.1 of the compound where R1=n-C15)131 in formula []
Dissolve g (0,5*ol) in 400ml of toluene, add 11.5g (0,5*ol) of metallic sodium,
The mixture was stirred and refluxed. After 2 hours, Hensyl Bromide 85.5
g (0,5-01) was added dropwise over a period of 1 hour, followed by IR reflux.
反応終了後、得られた溶液を濾過して不溶物を除き、減
圧蒸留して、DL−2,3−イソプロピリデングリセロ
ール−1−ベンジルエーテル93.8gを得た(収率8
4.4%)。更に、その80.0g (0,36*ol
)を10%(v/v)酢酸水溶液2001中で2時間還
流して脱保護し、減圧蒸留により、DL−グリセロール
−】−ヘンシルエーテル54.6g1t得た(収率83
.2%)。After the reaction was completed, the resulting solution was filtered to remove insoluble matter and distilled under reduced pressure to obtain 93.8 g of DL-2,3-isopropylidene glycerol-1-benzyl ether (yield: 8
4.4%). Furthermore, its 80.0g (0,36*ol
) was deprotected by refluxing in a 10% (v/v) acetic acid aqueous solution 2001 for 2 hours, and distilled under reduced pressure to obtain 54.6 g 1 t of DL-glycerol-]-hensyl ether (yield 83
.. 2%).
次いて得られたDL−グリセロール−1−ヘンシルエー
テル50.0g (0,27*ol)とピリジン43.
4g (0,54−ol)とを、四塩化炭素340m1
に溶解させた溶液に、四塩化炭素100m1に塩化バル
ミトイル150g(0,54■of)を溶解した溶液を
、攪拌下、室温で滴下し、更に40℃で4時間攪拌した
。析出した塩を除去後溶媒を留去し、エタノールからD
L−3〜ヘンシル−1,2−ジパルミトイルグリセロー
ルの白色結晶158gを得た(収率87.6%)。Then, 50.0 g (0.27*ol) of the obtained DL-glycerol-1-hensyl ether and 43.0 g of pyridine.
4g (0,54-ol) in 340ml of carbon tetrachloride
A solution of 150 g (0.54 ml) of balmitoyl chloride dissolved in 100 ml of carbon tetrachloride was added dropwise at room temperature with stirring, and the mixture was further stirred at 40° C. for 4 hours. After removing the precipitated salt, the solvent was distilled off and D
158 g of white crystals of L-3~hensyl-1,2-dipalmitoylglycerol were obtained (yield: 87.6%).
更に、得られた結晶150g (0,23*ol)をn
−ヘキサン1200m1中で、パラジウム黒を触媒とし
て、室温下に水素化し、熱時、触媒を濾別した後、結晶
化させ、0L−1,2−ジパルミトイルグリセロール(
化合物1)の白色結晶122gを得た(収率94.1%
)。Furthermore, 150 g (0,23*ol) of the obtained crystals were added to n
-Hydrogenate in 1200 ml of hexane using palladium black as a catalyst at room temperature, filter off the catalyst while hot, and crystallize.
122 g of white crystals of compound 1) were obtained (yield 94.1%).
).
(2)式[I]においてR’ = n−c15”3+
T:ある化合物の光学活性体
(1)に於けるDL−2,3−イソプロピリデングリセ
ロールをD−2,3−イソプロピリデングリセロール及
びL−2,3−イソプロピリデングリセロールに夫々代
えて(1)と同様に処理し、夫々相当する1、2ジパル
ミトイルグリセロール(化合物2,3)を得た。(2) In formula [I], R' = n-c15"3+
T: DL-2,3-isopropylideneglycerol in optically active form (1) of a certain compound is replaced with D-2,3-isopropylideneglycerol and L-2,3-isopropylideneglycerol (1) The corresponding 1 and 2 dipalmitoylglycerols (compounds 2 and 3) were obtained in the same manner as above.
(3)式[I]においてR’ = n−c17)135
及びn−C13■27である化合物のラセミ体及び光学
活性体、並びニR’=R’R″CH(R”(CH3)2
CHCH2(C)+3)C)lcH2c)+2.R”=
(CH3ン3CC)+2(C)+3>C)l テする
化合物のラセミ体
(1)及び(2)に於ける塩化バルミトイルを塩化ステ
アロイル及び塩化ミリストイルに夫々代えて(1)と同
様に処理し、夫々に相当する1、2−ジアシル化グリセ
ロール(化合物4〜9)を得た。(3) In formula [I], R' = n-c17)135
and racemic and optically active forms of the compound where n-C13■27, and R'=R'R''CH(R''(CH3)
CHCH2(C)+3)C)lcH2c)+2. R”=
(CH3-3CC)+2(C)+3>C)l Racemic form of the compound (1) and (2) were treated in the same manner as in (1), replacing balmitoyl chloride with stearoyl chloride and myristoyl chloride, respectively. , 1,2-diacylated glycerol (compounds 4 to 9) corresponding to each other were obtained.
また、(1)に於ける塩化バルミトイルを塩化2−(1
,3,3−)リメチルブチル)−5,7,7−ドリメチ
ルオクタノイルに代えて(1)と同様に処理し、相当す
るDL−1,2−ジアシル化グリセロール(化合物10
)を粘稠な液体として得た。In addition, balmitoyl chloride in (1) is replaced with 2-(1
, 3,3-)limethylbutyl)-5,7,7-drimethyloctanoyl and the corresponding DL-1,2-diacylated glycerol (compound 10
) was obtained as a viscous liquid.
以下余白
参考例2.ヒドロキシアルキル四級アンモニウム塩の製
造
(1)式[■コにおいてR2=CH3、n=2、Y=ρ
−トルエンスルホン酸イオン、ベンゼンスルホン酸イオ
ン、メタンスルホン酸イオン及びメチル硫酸イオン、で
ある化合物2−ヒドロキシ−N、N−ジメチルエチルア
ミン4.5g(0,05mol)及びp−)ルエンスル
ホン酸メチル9゜3g (0,05i+ol)をトルエ
ン501に溶解し、室温下2時間攪拌した。反応終了後
、析出した生成物をa!取し、N−(2−ヒドロキシ1
チル)−N、N、N−) IJ メチルアンモニウム
・p−トルエンスルホネート(化合物11)の白色結晶
11.43を得た。収率82.8%。Margin reference example 2 below. Production of hydroxyalkyl quaternary ammonium salt (1) In formula [■, R2=CH3, n=2, Y=ρ
- toluenesulfonate ion, benzenesulfonate ion, methanesulfonate ion and methylsulfate ion, the compound 2-hydroxy-N,N-dimethylethylamine 4.5 g (0.05 mol) and p-)methyl toluenesulfonate 9 3 g (0.05 i+ol) was dissolved in 501 toluene and stirred at room temperature for 2 hours. After the reaction is completed, the precipitated product is a! and N-(2-hydroxy 1
11.43 of white crystals of methyl ammonium p-toluenesulfonate (compound 11) were obtained. Yield 82.8%.
また、p−)ルエンスルホン酸メチルをベンゼンスルホ
ン酸メチル、メタンスルホン酸メチル及びジメチル硫酸
に夫々代えて同様に処理し、夫々相当するヒドロキシア
ルキル4級アンモニウム塩(化合物12〜]4)を得た
。In addition, the same treatment was carried out by replacing methyl p-)luenesulfonate with methyl benzenesulfonate, methyl methanesulfonate, and dimethyl sulfate, respectively, to obtain the corresponding hydroxyalkyl quaternary ammonium salts (compounds 12 to 4). .
尚、ジメチル硫酸を使用した場合は、生成物は液体で得
られ、反応液を濃縮したのみてあった。In addition, when dimethyl sulfate was used, the product was obtained in the form of a liquid, and the reaction solution was simply concentrated.
(2)式[■コにおいてR2= C)13c)12、Y
−=p−)ルエンスルホン酸イオン、n=2である化合
物
2−ヒドロキシ−N、N−ジエチルエチルアミン5.9
8(0,05mol)及びp−トルエンスルホン酸エチ
ル10.13 (0,05mol)をキシレン501に
溶解し、5時間攪拌した。反応終了後、減圧下に溶媒を
留去し、N、N、N−)リエチルーN−(2−ヒドロキ
シエチル)アンモニウム・p−トルエンスルホネート(
化合物15)15.6gを淡黄色油状物として得た。収
率98.0%。(2) In formula [■, R2 = C) 13c) 12, Y
-=p-) luenesulfonate ion, compound 2-hydroxy-N,N-diethylethylamine with n=2 5.9
8 (0.05 mol) and 10.13 (0.05 mol) of ethyl p-toluenesulfonate were dissolved in xylene 501 and stirred for 5 hours. After the reaction, the solvent was distilled off under reduced pressure and N,N,N-)riethyl-N-(2-hydroxyethyl)ammonium p-toluenesulfonate (
15.6 g of compound 15) was obtained as a pale yellow oil. Yield 98.0%.
(3)式[■コにおいてR2=CH3、y−=p−トル
エンスルホン酸イオン、n=3である化合物
(1)に於ける2−ヒドロキシ−N、N−ジメチルエチ
ルアミンを3−ヒドロキシ−N、N−ジメチルプロピル
アミンに代えて(1)と同様に処理し、N−(3−ヒド
ロキシプロピル)−N、N、N−)リメチルアンモニウ
ム・p−)ルエンスルホネート(化合物16)の白色結
晶s、ogを得た。収率55.0%。(3) 2-hydroxy-N,N-dimethylethylamine in compound (1) where R2=CH3, y-=p-toluenesulfonic acid ion, n=3 in formula [■] , Substituting N-dimethylpropylamine and treating in the same manner as in (1), white crystals of N-(3-hydroxypropyl)-N,N,N-)limethylammonium p-)luenesulfonate (compound 16) were obtained. s, og was obtained. Yield 55.0%.
実施例1 、 DL−1,2−ジパルミトイルグリセロ
ールのジクロロリン酸エステル(式[■コ
においてR’ = n−clsH31、X=CIである
化合物のラセミ体)の製造
オキシ塩化リン3.1g (20mmol)及びトリエ
チルアミン10.23 (100**ol)をクロロホ
ルム601に溶解した溶液に、同溶媒15−1に化合物
11.1g(2m1Io I )を溶解した溶液を、攪
拌下、0℃で1時間30分を要して滴下し、更に3〜2
0℃で3時間攪拌した。次いて、50℃で減圧下に濃縮
した後、ジエチルエーテル50−1に再溶解して、不溶
物を除いた。再度、減圧下に濃縮して完全に溶媒を留去
し、DL−1,2−ジパルミトイルグリセロールのジク
ロロリン酸エステル1.38gを黄褐色ロウ状固体とし
て得た。収率100%。Example 1. Preparation of dichlorophosphate ester of DL-1,2-dipalmitoylglycerol (racemic compound of the formula [■, where R' = n-clsH31, X = CI) 3.1 g of phosphorus oxychloride ( 20 mmol) and triethylamine 10.23 (100**ol) dissolved in chloroform 601, a solution of compound 11.1 g (2 ml Io I) dissolved in the same solvent 15-1 was added to a solution of 11.1 g (2 ml Io I ) of the same solvent at 0° C. for 1 hour with stirring. It took 30 minutes to drip, and then another 3 to 2
The mixture was stirred at 0°C for 3 hours. Next, the residue was concentrated under reduced pressure at 50°C, and then redissolved in diethyl ether 50-1 to remove insoluble matter. The solvent was again completely distilled off under reduced pressure to obtain 1.38 g of dichlorophosphoric acid ester of DL-1,2-dipalmitoylglycerol as a yellow-brown waxy solid. Yield 100%.
融点:32〜53℃
I Rj;;!i’A : v cta ’ 2940
.2860.1755.1475゜’ H−N M R
(CDCI 3) :δpp+n O,88(t、6)
1.C且−り、1.26(S、48H,(CH2)l
2)、1.62(Im、4H,C0CH2C且2)、2
.32(s+、4)1.C0Cj12)、3.66(−
,2H,C旦。−0P03)、4.22.4.35(s
、2H,CH,0CO)、5.23(w、01.C且)
実施例2.DL−ジパルミトイルホスファチジルコリン
(式[IV]においてR’ =n−C15H3、R2=
CH3、n=2である化合物のラセミ体)の製造
実施例1て得られたDL−1,2−ジパルミトイルグリ
セロールのジクロロリン酸エステル6.9g(10゜2
s+mol)をクロロホルム1051に溶解し、これに
、ピリジン1401に化合物114.0g (14,5
+w+wol)を溶解した溶液を、攪拌下、0℃で1時
間を要して滴下し更に室温で攪拌した。Melting point: 32-53°C I Rj;;! i'A: v cta' 2940
.. 2860.1755.1475゜' H-N M R
(CDCI 3): δpp+n O, 88 (t, 6)
1. C, 1.26 (S, 48H, (CH2)l
2), 1.62 (Im, 4H, C0CH2C and 2), 2
.. 32(s+, 4)1. C0Cj12), 3.66(-
, 2H, C-dan. -0P03), 4.22.4.35(s
, 2H, CH, 0CO), 5.23 (w, 01.C and) Example 2. DL-dipalmitoylphosphatidylcholine (in formula [IV], R' = n-C15H3, R2 =
Production of a racemic compound (CH3, n=2) 6.9 g (10°2
s + mol) was dissolved in chloroform 1051, and 114.0 g (14,5 mol) of the compound was dissolved in pyridine 1401.
+w+wol) was added dropwise under stirring at 0° C. over 1 hour, and the mixture was further stirred at room temperature.
12時間経過後、炭酸水素ナトリウム6.78を溶解さ
せた水76.7gを加え、室温で30分閏攪拌したのち
、反応液を減圧下に濃縮した。得られた残渣をシリカゲ
ルを吸着剤として、カラムクロマトグラフィーに付し、
D、L−ジパルミトイルホスファチジルコリン(化合物
17)の白色結晶4.78を得た。After 12 hours had passed, 76.7 g of water in which 6.78 of sodium hydrogen carbonate had been dissolved was added, and after stirring at room temperature for 30 minutes, the reaction solution was concentrated under reduced pressure. The obtained residue was subjected to column chromatography using silica gel as an adsorbent,
4.78 g of white crystals of D,L-dipalmitoylphosphatidylcholine (compound 17) were obtained.
収率64.3%。Yield 64.3%.
実施例3.同上
オキシ塩化リン1.568(Io、2m*ol)及びト
リエチルアミン5.063 (50+wmol)をクロ
ロホルム35m1に溶解した溶液に、同溶媒701に化
合物15.7g(10*mol)を溶解した溶液を、攪
拌下、0℃で1時間を要して滴下し、更に室温で1時間
攪拌した。Example 3. A solution of 15.7 g (10*mol) of the compound dissolved in the same solvent 701 was added to a solution of 1.568 (Io, 2 m*ol) of the same phosphorus oxychloride and 5.063 (50+wmol) of triethylamine dissolved in 35 ml of chloroform. The mixture was added dropwise over 1 hour at 0° C. with stirring, and further stirred at room temperature for 1 hour.
次いて、ピリジン1401に化合物II 4.(Ig
(14,5+mmol)を溶解した溶液を、攪拌下、0
℃で1時間を要して滴下し更に室温で攪拌した。Then compound II was added to pyridine 1401 4. (Ig
(14,5+mmol) was dissolved in a solution of 0.0
The mixture was added dropwise over a period of 1 hour at ℃ and further stirred at room temperature.
12時間経過後、炭酸水素ナトリウム6.78を溶解さ
せた水76.73を加え、室温で30分閏攪拌したのち
、反応液を減圧下に濃縮した。得られた残渣をシリカゲ
ルを吸着剤として、カラムクロマトグラフィーに付し、
化合物17の白色結晶4.68を得た。収率62.6%
。After 12 hours had passed, 76.73 ml of water in which 6.78 ml of sodium hydrogen carbonate had been dissolved was added, and after stirring at room temperature for 30 minutes, the reaction solution was concentrated under reduced pressure. The obtained residue was subjected to column chromatography using silica gel as an adsorbent,
4.68 g of white crystals of Compound 17 were obtained. Yield 62.6%
.
実施例4.同上
実施例3に於ける化合物11を化合物12〜14に夫々
代えて実施例3と同様に処理し、夫々59.9%。Example 4. Compound 11 in Example 3 above was replaced with Compounds 12 to 14, respectively, and the same treatment as in Example 3 was performed, each yielding 59.9%.
9.5%及び65.4%の収率て化合物17を得た。Compound 17 was obtained with yields of 9.5% and 65.4%.
実施例4.各種ジアシル化ホスファチジルコリンの製造
実施例3に於ける化合物lを化合物2〜10に夫々代え
て実施例3と同様に処理し、夫々に相当するジアシル化
ホスファチジルコリン(化合物18〜26)を得た。尚
、化合物26は、常温でペースト状物質として得られた
。Example 4. Production of various diacylated phosphatidylcholines Compound 1 in Example 3 was replaced with compounds 2 to 10, and the same procedure as in Example 3 was carried out to obtain the corresponding diacylated phosphatidylcholines (compounds 18 to 26). Note that Compound 26 was obtained as a paste-like substance at room temperature.
実施例5.同上
実施例3に於ける化合物11を化合物15及び16に夫
々代えて実施例3と同様に処理し、夫々相当するジアシ
ル化ホスファチジルコリン類似体(化合物27.28)
を得た。Example 5. Compound 11 in Example 3 above was replaced with compounds 15 and 16, respectively, and the same treatment as in Example 3 was carried out to obtain the corresponding diacylated phosphatidylcholine analogues (compounds 27 and 28).
I got it.
E発明の効果コ
本発明は、トリメチルアミンの如き低沸点の原料や、銀
化合物の如き重金属化合物の使用を回避することにより
、環境汚染の問題を生じず、かつ、簡易に実施できるホ
スファチジルコリン誘導体の製造方法を提供した点に顕
著な効果を奏する発明である。E Effects of the Invention The present invention provides a method for producing phosphatidylcholine derivatives that does not cause environmental pollution and can be easily carried out by avoiding the use of low boiling point raw materials such as trimethylamine and heavy metal compounds such as silver compounds. This invention has a remarkable effect in that it provides a method.
特許出願人 和光純薬工業株式会社 平成3年5月2日Patent applicant: Wako Pure Chemical Industries, Ltd. May 2, 1991
Claims (1)
のアルキル基を表す。) で示される化合物に、オキシハロゲン化リンを反応させ
て、式[II] ▲数式、化学式、表等があります▼[II] (式中、Xはハロゲン原子を表し、R^1は前記と同じ
。) で示される化合物とし、三級アミンの存在下、これに、
式[III] HO(CH_2)_nN^+R^2_3・Y^−[III
](式中、R^2は低級アルキル基を表し、Y^−は硫
酸イオン、アルキル硫酸イオン又はスルホン酸イオンを
表し、nは2〜10の整数を表す。) で示される化合物を反応させ、次いで、塩基性物質の存
在下、水と反応させる、式[IV] ▲数式、化学式、表等があります▼[IV] (式中、R^1、R^2及びnは前記と同し。)で示さ
れるホスファチジルコリン誘導体の製造方法。 2.式[II] ▲数式、化学式、表等があります▼[II] (式中、R^1は炭素数10〜24の直鎖状又は分枝状
のアルキル基を表し、Xはハロゲン原子を表す。)で示
される化合物に、三級アミンの存在下、式[III] HO(CH_2)_nN^+R^2_3・Y^−[III
](式中、R^2は低級アルキル基を表し、Y^−は硫
酸イオン、アルキル硫酸イオン又はスルホン酸イオンを
表し、nは2〜10の整数を表す。) で示される化合物を反応させ、次いで、塩基性物質の存
在下、水と反応させる、式[IV] ▲数式、化学式、表等があります▼[IV] (式中、R^1、R^2及びnは前記と同じ。)で示さ
れるホスファチジルコリン誘導体の製造方法。 3、R^1が炭素数13〜17の直鎖状のアルキル基で
あり、R^2がメチル基であり、nが2である請求項1
又は2記載の方法。 4、Xが塩素原子であり、Y^−がアルキル硫酸イオン
又は芳香族スルホン酸イオンである請求項1、2又は3
記載の方法。 5、式[II] ▲数式、化学式、表等があります▼[II] (式中、R^1は炭素数10〜24の直鎖状又は分枝状
のアルキル基を表し、Xはハロゲン原子を表す。)で示
される化合物。 6、Xが塩素原子である請求項5記載の化合物。[Claims] 1. Formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R^1 represents a linear or branched alkyl group having 10 to 24 carbon atoms.) The compound represented by is reacted with phosphorus oxyhalide to form the formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [II] (In the formula, X represents a halogen atom, and R^1 is the same as above. ), and in the presence of a tertiary amine, to this,
Formula [III] HO(CH_2)_nN^+R^2_3・Y^-[III
] (In the formula, R^2 represents a lower alkyl group, Y^- represents a sulfate ion, an alkyl sulfate ion, or a sulfonate ion, and n represents an integer of 2 to 10.) , then react with water in the presence of a basic substance, formula [IV] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [IV] (In the formula, R^1, R^2 and n are the same as above. .) A method for producing a phosphatidylcholine derivative. 2. Formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [II] (In the formula, R^1 represents a linear or branched alkyl group having 10 to 24 carbon atoms, and X represents a halogen atom. ), in the presence of a tertiary amine, the formula [III] HO(CH_2)_nN^+R^2_3・Y^-[III
] (In the formula, R^2 represents a lower alkyl group, Y^- represents a sulfate ion, an alkyl sulfate ion, or a sulfonate ion, and n represents an integer of 2 to 10.) , then react with water in the presence of a basic substance, formula [IV] ▲ Numerical formulas, chemical formulas, tables, etc. ▼ [IV] (In the formula, R^1, R^2 and n are the same as above. ) A method for producing a phosphatidylcholine derivative. 3. Claim 1, wherein R^1 is a linear alkyl group having 13 to 17 carbon atoms, R^2 is a methyl group, and n is 2.
Or the method described in 2. 4.Claim 1, 2 or 3, wherein X is a chlorine atom and Y^- is an alkyl sulfate ion or an aromatic sulfonate ion.
Method described. 5. Formula [II] ▲Mathematical formulas, chemical formulas, tables, etc.▼[II] (In the formula, R^1 represents a linear or branched alkyl group having 10 to 24 carbon atoms, and X is a halogen atom. ). 6. The compound according to claim 5, wherein X is a chlorine atom.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12388790A JP2869572B2 (en) | 1990-05-14 | 1990-05-14 | Method for producing phosphatidylcholine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12388790A JP2869572B2 (en) | 1990-05-14 | 1990-05-14 | Method for producing phosphatidylcholine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0421691A true JPH0421691A (en) | 1992-01-24 |
JP2869572B2 JP2869572B2 (en) | 1999-03-10 |
Family
ID=14871822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12388790A Expired - Fee Related JP2869572B2 (en) | 1990-05-14 | 1990-05-14 | Method for producing phosphatidylcholine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2869572B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001515082A (en) * | 1997-08-18 | 2001-09-18 | マツクス−プランク−ゲゼルシヤフト ツール フエルデルング デル ヴイツセンシヤフテン エー フアウ | Phospholipid-like compounds |
JP2010209107A (en) * | 2004-07-09 | 2010-09-24 | Vascular Biogenics Ltd | Improved process for preparation of oxidized phospholipid |
US8563534B2 (en) | 2000-11-24 | 2013-10-22 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
US8759557B2 (en) | 2004-07-09 | 2014-06-24 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9206206B2 (en) | 2008-11-06 | 2015-12-08 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
US10022388B2 (en) | 2014-11-26 | 2018-07-17 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
WO2020070836A1 (en) * | 2018-10-03 | 2020-04-09 | 日立化成株式会社 | Resin composition, wrapping film, and wrapping film housing body |
-
1990
- 1990-05-14 JP JP12388790A patent/JP2869572B2/en not_active Expired - Fee Related
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7595411B2 (en) | 1997-08-18 | 2009-09-29 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Phospholipid-analogous compounds |
JP2010018625A (en) * | 1997-08-18 | 2010-01-28 | Max-Planck-Ges Zur Foerderung Der Wissenschaften Ev | Phospholipid-like compound |
JP2001515082A (en) * | 1997-08-18 | 2001-09-18 | マツクス−プランク−ゲゼルシヤフト ツール フエルデルング デル ヴイツセンシヤフテン エー フアウ | Phospholipid-like compounds |
US7939683B2 (en) | 1997-08-18 | 2011-05-10 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Phospholipid-analogous compounds |
US8497388B2 (en) | 1997-08-18 | 2013-07-30 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften. E.V. | Phospholipid-analogous compounds |
US8563534B2 (en) | 2000-11-24 | 2013-10-22 | Vascular Biogenics Ltd. | Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
US8759557B2 (en) | 2004-07-09 | 2014-06-24 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
JP2010209107A (en) * | 2004-07-09 | 2010-09-24 | Vascular Biogenics Ltd | Improved process for preparation of oxidized phospholipid |
US8802875B2 (en) | 2004-07-09 | 2014-08-12 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
US8569529B2 (en) | 2007-01-09 | 2013-10-29 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9006217B2 (en) | 2007-01-09 | 2015-04-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9566288B2 (en) | 2007-01-09 | 2017-02-14 | Vascular Biogenics Ltd. | High-purity phospholipids |
US9206206B2 (en) | 2008-11-06 | 2015-12-08 | Vascular Biogenics Ltd. | Oxidized lipid compounds and uses thereof |
US9771385B2 (en) | 2014-11-26 | 2017-09-26 | Vascular Biogenics Ltd. | Oxidized lipids |
US10022388B2 (en) | 2014-11-26 | 2018-07-17 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
US10206936B2 (en) | 2014-11-26 | 2019-02-19 | Vascular Biogenics Ltd. | Oxidized lipids and treatment or prevention of fibrosis |
US10464957B2 (en) | 2014-11-26 | 2019-11-05 | Vascular Biogenics Ltd. | Oxidized lipids and methods of use thereof |
WO2020070836A1 (en) * | 2018-10-03 | 2020-04-09 | 日立化成株式会社 | Resin composition, wrapping film, and wrapping film housing body |
Also Published As
Publication number | Publication date |
---|---|
JP2869572B2 (en) | 1999-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100555970B1 (en) | A process for preparing 2-amino-1,3-propandiol derivatives | |
AT405283B (en) | NEW CRYSTALLINE 7- (Z) - (2- (2-AMINOTHIAZOL-4-YL) -2-HYDROXYIMINOACETAMIDO) -3-VINYL-3-CEPHEM-4- CARBONIC ACID DICYCLOHEXYLAMMONIUM SALTS AND METHODS FOR THE PRODUCTION THEREOF | |
SU1333234A3 (en) | Method of producing the derivatives of n-phenylbenzamide or salts thereof | |
DK159680B (en) | CYCLIC IMIDES USED FOR THE PREPARATION OF CYCLIC AMINO ACIDS | |
JPH0421691A (en) | Production of phosphatidylcholine derivative and its analog and their intermediate | |
BR102017014724A2 (en) | PROCESSES FOR PREPARING 4-ALCoxy-3- (ACYL OR ALKYL) OXIPICOLINAMIDS | |
RU2762891C2 (en) | Methods for producing benzodiazepine cytotoxic derivatives | |
CN114805314A (en) | Synthesis method of Ensaitevir | |
EA005209B1 (en) | Phase transfer catalyzed glycosidation of an indolocarbazole | |
JPS6033114B2 (en) | 1,2-benzisoxazole derivative | |
NO180230B (en) | 2-amino-1,2,3,4-tetrahydronaphthalene derivatives with cardiovascular activity and pharmaceutical preparations containing such | |
US2717268A (en) | Process for preparing phenyldichloro-acetamidopropanediols | |
DE60022684T2 (en) | Process for the preparation of 6-methyl-2- (4-methyl-phenyl) -imidazo [1,2-A] pyridine-3- (N, N-dimethyl-acetamide) and intermediates | |
JPH02188570A (en) | Production of halogen-substituted quinoline derivative | |
NZ210133A (en) | Optical resolution of racemic mixtures alpha-naphthyl-propionic acids, and intermediate amides | |
SU623524A3 (en) | Method of obtaining 1-n-substituted derivatives of 4-6-di(aminoglycosil)-1,3-diaminocyclitols or salts thereof | |
EP1828149A1 (en) | Method for the production of oxazoles by condensing aromatic aldehydes with a-ketoximes to n-oxides and then reacting the same with activated acid derivatives | |
US4238622A (en) | D,L-2-Amino-4-(2-aminoethoxy)-trans-but-3-enoic acid derivatives | |
US5149857A (en) | Process for production of sulfonium compounds | |
EP4249468A1 (en) | A method for synthesis of halide salts | |
JPH04169583A (en) | Phenothiazine derivative and its production | |
US5011973A (en) | Novel process for producing bischoline-disulfonate derivatives | |
JP2000503993A (en) | Method for producing N- (3-amino-4-chlorophenyl) acylamide | |
US2789981A (en) | Bis-carbamic acid ester compounds, and a process of making same | |
US3751462A (en) | Process for preparation of substituted fluoromethanesulfonanilides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |